# A Bioequivalence Study Comparing Clopidogrel/Aspirin Combination Tablet With Coadministration of Clopidogrel and Aspirin

> **NCT01448330** · PHASE1 · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 64 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HCP0911 / clopidogrel, aspirin

## Key facts

- **NCT ID:** NCT01448330
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2011-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01448330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01448330, "A Bioequivalence Study Comparing Clopidogrel/Aspirin Combination Tablet With Coadministration of Clopidogrel and Aspirin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01448330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*